HC Wainwright & Co. maintains ESSA Pharma [EPIX] at Buy rating with a $17 price target
HC Wainwright & Co. maintained its ESSA Pharma [EPIX] rating to the equivalent of Buy but changed the price target to $17.0 from $10, in a research note dated 2021-01-11. That figure represents around a 41.43% premium from where the company’s shares closed on Friday. Some new analysts also started their coverage, with Oppenheimer’s analysts […]
Insider Selling Report: Applied Therapeutics Inc. [APLT]’s Chief Medical Officer, Perfetti Riccardo, Sells 16,515 Shares
On Jan. 06, Perfetti Riccardo divested U.S. $383,711 in shares of Applied Therapeutics Inc.. The Chief Medical Officer sold 16,515 shares at a price per share of $23.23. The transaction decreased this specific insider’s holdings to 0 shares worth around $0.0 at present. Truist launched its Applied Therapeutics Inc. [APLT] rating to the equivalent of […]
Andersons [ANDE] gets a downgrade to Market Perform from BMO Capital
BMO Capital took its Andersons [ANDE] rating to the equivalent of Market Perform from Outperform, and the price target to $26.0 from $24, in a research note dated 2021-01-11. That figure represents around a 3.26% premium from where the company’s shares closed on Friday. Other analysts also revised their coverage, with BMO Capital Markets’s analysts […]
Insider Selling Report: Horizon Therapeutics Public Limited Company [HZNP]’s EVP, Chief HR Off, Konstantinovsky Irina, Sells 26,844 Shares
On Jan. 06, Konstantinovsky Irina divested U.S. $2,006,854 in shares of Horizon Therapeutics Public Limited Company. The EVP, Chief HR Off sold 26,844 shares at a price per share of $74.76. The transaction decreased this specific insider’s holdings to 86,499 shares worth around $6.88 million at present. Another 27,106 shares were sold by Desjardin Michael […]
Datadog [DDOG] Stock Gets an Upgrade from Jefferies. It’s Now Buy
Jefferies took its Datadog [DDOG] rating to the equivalent of Buy from Hold, in a research note dated 2021-01-11. Some new analysts also started their coverage, with KeyBanc Capital Markets’s analysts assigning the shares to “a Sector weight” rating in a research note to investors issued in late November. Meanwhile, Monness Crespi & Hardt had […]
Stoecker Dean Has Sold $1,692,063 in Alteryx Inc. [AYX] Stock
On Jan. 06, Stoecker Dean divested U.S. $1,692,063 in shares of Alteryx Inc.. The Dir, 10% sold 15,000 shares at a price per share of $112.80. The transaction decreased this specific insider’s holdings to 231,599 shares worth around $26.98 million at present. Get the hottest stocks to trade every day before the market opens 100% […]
Watch out why AzurRx BioPharma (AZRX) shares are on the rise in the pre-market
James Sapirstein, President and Chief Executive Officer of AzurRx BioPharma (NASDAQ: AZRX), has issued the following letter to its shareholders and the investment community. Get the hottest stocks to trade every day before the market opens 100% free. Click here now. Here are the Highlights… Let’s begin this year with great optimism and look forward […]
Fenster Edward Harris Has Sold $4,455,000 in Sunrun Inc. [RUN] Stock
On Jan. 07, Fenster Edward Harris divested U.S. $4,455,000 in shares of Sunrun Inc.. The COB sold 50,000 shares at a price per share of $89.10. The transaction decreased this specific insider’s holdings to 1,599,513 shares worth around $154.35 million at present. Another 60,000 shares were sold by Dawson Christopher, for more than $5,100,162 in […]
Baird lowers Albany International [AIN] rating to Neutral and sets price target at $79
Baird took its Albany International [AIN] rating to the equivalent of Neutral from Outperform, and the price target to $79.0 from $70, in a research note dated 2021-01-11. That figure represents around a 3.74% premium from where the company’s shares closed on Friday. Meanwhile, Robert W. Baird had raised its rating on AIN to “an […]
RBC Capital raises Royal Gold [RGLD]’s rating to Outperform and price target to $150
RBC Capital took its Royal Gold [RGLD] rating to the equivalent of Outperform from Sector Perform, and the price target to $150 from $155, in a research note dated 2021-01-11. That figure represents around a 42.05% premium from where the company’s shares closed on Friday. Other analysts also revised their coverage, with RBC Capital Mkts’s […]
